Skip to main content

Table 5 Waiting time audit and estimated waiting time

From: Utilization of breast MRI and breast MRI-guided biopsy in clinical practice: results of a survey in Québec and France

  Québec France p value
χ2 test
  Proportions 95% CI Proportions 95% CI
Auditing waiting time
Yes 80% (16/21) [60.8–99.2] 68.1% (81/119) [59.6–76.6] 0.282
Average waiting time breast MRI
< 1 week 0% (0/21) [0–0] 16.8% (21/119) [10–23.6] 0.048
1–2 weeks 5% (1/21) [5.5–15.5] 44.6% (53/119) [35.5–53.6] 0.001
2–3 weeks 25% (5/21) [4.2–75.8] 25.2% (30/119) [17.3–33.1] 0.984
> 3 weeks 55% (11/21) [31.1–78.9] 12.6% (15/119) [6.5–18.7] < 0.0001
Unsure 15% (3/21) [2.1–32.1] 0.8% (1/119) [0.8–2.5] < 0.0001
Waiting time breast MRI opinion
Adequate 68.4% (13/19) [45.4–91.4] 72 % (85/118) [63.8–80.2] 0.746
Too long 31.6% (6/19) [8.6–54.6] 28 % (33/118) [19.7–36.2] 0.746
Average waiting time preoperative breast MRI
< 1 week 5% (1/21) [5.5–15.5] 40.3% (48/119) [31.4–49.3] 0.002
1–2 weeks 40% (8/21) [16.5–63.5] 52.1% (62/119) [43–61.2] 0.317
2–3 weeks 30% (6/21) [8–52] 6.7% (8/119) [2.2–11.3] 0.001
> 3 weeks 10% (2/21) [4.4–24.4] 0% (0/119) [0–0] 0.001
Unsure 15% (3/21) [2.1–32.1] 0.9% (1/119) [0.8–2.5] < 0.0001
Waiting time preoperative breast MRI opinion
Adequate 85% (17/21) [67.8–102.1] 81.5% (97/119) [74.4–88.6] 1.000
Too long 15% (3/21) [2.1–32.1] 18.5% (22/119) [11.4–25.6] 1.000
  1. Note—Data in parentheses are ratio